SCHEMBL18813105

SCHEMBL18813105

CN1CCN(CCNC(=O)O)CC1.COc1ccc(-n2nnc3cnc(NC4CCCC4)nc32)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 11/20 0.62
▸ GSK3A P49840 3/20 0.48
▸ GSK3B P49841 3/20 0.48
▸ CCNA2 P20248 2/20 0.45
▸ CDK2 P24941 2/20 0.45
▸ CCNA1 P78396 2/20 0.45
▸ AURKA O14965 2/20 0.45
▸ EIF2AK4 Q9P2K8 1/20 0.44
▸ KDM5B Q9UGL1 1/20 0.43
▸ BMPR1B O00238 1/20 0.41
▸ BMPR1A P36894 1/20 0.41
▸ TGFBR1 P36897 1/20 0.41
▸ ACVRL1 P37023 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17435308 0.87 MAPK6 (0.65) MAPK6GSK3AGSK3BEIF2AK4
Bicarbonate SCHEMBL18813022 0.86 MAPK6 (0.78) MAPK6GSK3AGSK3BCCNA2CDK2
SCHEMBL18813078 0.86 GSK3A (0.44) MAPK6GSK3AGSK3BEIF2AK4KDM5B
SCHEMBL18813097 0.85 EIF2AK4 (0.47) MAPK6GSK3AGSK3BEIF2AK4BMPR1B
Carbamic Acid SCHEMBL18813032 0.84 MAPK6 (0.81) MAPK6GSK3AGSK3BCCNA2CDK2
Carbamic Acid SCHEMBL18813068 0.83 MAPK6 (0.80) MAPK6GSK3AGSK3BCCNA2CDK2
SCHEMBL16012225 0.83 MAPK6 (0.82) MAPK6GSK3AGSK3BCCNA2CDK2
Dimethylcarbate SCHEMBL18813036 0.83 MAPK6 (0.73) MAPK6GSK3AGSK3BCCNA2CDK2
Carbamic Acid SCHEMBL18813103 0.83 MAPK6 (0.81) MAPK6GSK3AGSK3BCCNA2CDK2
SCHEMBL16022028 0.82 MAPK6 (0.78) MAPK6GSK3AGSK3BEIF2AK4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP claimed
Send feedback